{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T20:57:45Z","timestamp":1792357065472,"version":"4.4.0"},"reference-count":66,"publisher":"American Society of Hematology","issue":"12","license":[{"start":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:00:00Z","timestamp":1713484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6,25]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>von Willebrand factor (VWF) undergoes complex posttranslational modification within endothelial cells (ECs) before secretion. This includes significant N- and O-linked glycosylation. Previous studies have demonstrated that changes in N-linked glycan structures significantly influence VWF biosynthesis. In contrast, although abnormalities in VWF O-linked glycans (OLGs) have been associated with enhanced VWF clearance, their effect on VWF biosynthesis remains poorly explored. Herein, we report a novel role for OLG determinants in regulating VWF biosynthesis and trafficking within ECs. We demonstrate that alterations in OLGs (notably reduced terminal sialylation) lead to activation of the A1 domain of VWF within EC. In the presence of altered OLG, VWF multimerization is reduced and Weibel-Palade body (WPB) formation significantly impaired. Consistently, the amount of VWF secreted from WPB after EC activation was significantly reduced in the context of O-glycosylation inhibition. Finally, altered OLG on VWF not only reduced the amount of VWF secreted after EC activation but also affected its hemostatic efficacy. Notably, VWF secreted after WPB exocytosis consisted predominantly of low molecular weight multimers, and the length of tethered VWF string formation on the surface of activated ECs was significantly reduced. In conclusion, our data therefore support the hypothesis that alterations in O-glycosylation pathways directly affect VWF trafficking within human EC. These findings are interesting given that previous studies have reported altered OLG on plasma VWF (notably increased T-antigen expression) in patients with von Willebrand disease.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2023012499","type":"journal-article","created":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T19:20:58Z","timestamp":1713554458000},"page":"3254-3266","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":11,"title":["O-glycan determinants regulate VWF trafficking to Weibel-Palade bodies"],"prefix":"10.1182","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4082-076X","authenticated-orcid":false,"given":"Ellie","family":"Karampini","sequence":"first","affiliation":[{"name":"1Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9759-062X","authenticated-orcid":false,"given":"Dearbhla","family":"Doherty","sequence":"additional","affiliation":[{"name":"1Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7832-8028","authenticated-orcid":false,"given":"Petra E.","family":"B\u00fcrgisser","sequence":"additional","affiliation":[{"name":"2Department of Hematology, Erasmus Medical Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9332-0270","authenticated-orcid":false,"given":"Massimiliano","family":"Garre","sequence":"additional","affiliation":[{"name":"3Super-Resolution Imaging Consortium, Department of Chemistry, Royal College of Surgeons in Ireland, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5699-1160","authenticated-orcid":false,"given":"Ingmar","family":"Schoen","sequence":"additional","affiliation":[{"name":"1Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6297-4308","authenticated-orcid":false,"given":"Stephanie","family":"Elliott","sequence":"additional","affiliation":[{"name":"1Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1205-9689","authenticated-orcid":false,"given":"Ruben","family":"Bierings","sequence":"additional","affiliation":[{"name":"2Department of Hematology, Erasmus Medical Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0309-3313","authenticated-orcid":false,"given":"James S.","family":"O\u2019Donnell","sequence":"additional","affiliation":[{"name":"1Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland"},{"name":"4National Coagulation Centre, St James\u2019s Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,6,14]]},"reference":[{"issue":"21","key":"2024062514452995100_bib1","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMra1601561","article-title":"von Willebrand's disease","volume":"375","author":"Leebeek","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"2024062514452995100_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.cb.06.110190.001245","article-title":"Cell biology of von Willebrand factor","volume":"6","author":"Wagner","year":"1990","journal-title":"Annu Rev Cell Biol"},{"issue":"13","key":"2024062514452995100_bib3","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1182\/blood-2014-06-528406","article-title":"von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends","volume":"125","author":"Lenting","year":"2015","journal-title":"Blood"},{"issue":"19","key":"2024062514452995100_bib4","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1182\/blood-2012-10-415000","article-title":"Elucidating the role of carbohydrate determinants in regulating hemostasis: insights and opportunities","volume":"121","author":"Preston","year":"2013","journal-title":"Blood"},{"issue":"11","key":"2024062514452995100_bib5","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1021\/bi00359a015","article-title":"Amino acid sequence of human von Willebrand factor","volume":"25","author":"Titani","year":"1986","journal-title":"Biochemistry"},{"issue":"2","key":"2024062514452995100_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/BJ20120810","article-title":"Mapping the N-glycome of human von Willebrand factor","volume":"447","author":"Canis","year":"2012","journal-title":"Biochem J"},{"issue":"1-4","key":"2024062514452995100_bib7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000046450","article-title":"Glycoproteins and their relationship to human disease","volume":"161","author":"Brockhausen","year":"1998","journal-title":"Acta Anat"},{"issue":"8","key":"2024062514452995100_bib8","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/anie.201002313","article-title":"The Tn antigen-structural simplicity and biological complexity","volume":"50","author":"Ju","year":"2011","journal-title":"Angew Chem Int Ed Engl"},{"issue":"2","key":"2024062514452995100_bib9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1515\/BC.2001.022","article-title":"O-glycosylation of the mucin type","volume":"382","author":"Hanisch","year":"2001","journal-title":"Biol Chem"},{"issue":"1","key":"2024062514452995100_bib10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1538-7836.2009.03665.x","article-title":"The plasma von Willebrand factor O-glycome comprises a surprising variety of structures including ABH antigens and disialosyl motifs","volume":"8","author":"Canis","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"issue":"4","key":"2024062514452995100_bib11","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/jth.13260","article-title":"Site-specific analysis of von Willebrand factor O-glycosylation","volume":"14","author":"Solecka","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"issue":"7","key":"2024062514452995100_bib12","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1055\/s-0041-1726373","article-title":"The biological significance of von Willebrand factor O-linked glycosylation","volume":"47","author":"Ward","year":"2021","journal-title":"Semin Thromb Hemost"},{"issue":"7","key":"2024062514452995100_bib13","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/jth.14471","article-title":"von Willebrand factor sialylation-a critical regulator of biological function","volume":"17","author":"Ward","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"issue":"25","key":"2024062514452995100_bib14","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood.2020005843","article-title":"The relationship between ABO blood group, von Willebrand factor, and primary hemostasis","volume":"136","author":"Ward","year":"2020","journal-title":"Blood"},{"issue":"1","key":"2024062514452995100_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1538-7836.2003.00007.x","article-title":"An influence of ABO blood group on the rate of proteolysis of von Willebrand factor by ADAMTS13","volume":"1","author":"Bowen","year":"2003","journal-title":"J\u00a0Thromb Haemost"},{"issue":"25","key":"2024062514452995100_bib16","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1182\/blood-2013-04-496851","article-title":"Altered glycosylation of platelet-derived von Willebrand factor confers resistance to ADAMTS13 proteolysis","volume":"122","author":"McGrath","year":"2013","journal-title":"Blood"},{"issue":"13","key":"2024062514452995100_bib17","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1182\/blood-2009-09-241547","article-title":"Expression of terminal alpha2-6-linked sialic acid on von Willebrand factor specifically enhances proteolysis by ADAMTS13","volume":"115","author":"McGrath","year":"2010","journal-title":"Blood"},{"issue":"6","key":"2024062514452995100_bib18","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1182\/blood-2007-06-095042","article-title":"N-linked glycosylation of VWF modulates its interaction with ADAMTS13","volume":"111","author":"McKinnon","year":"2008","journal-title":"Blood"},{"issue":"15","key":"2024062514452995100_bib19","doi-asserted-by":"crossref","first-page":"5538","DOI":"10.1016\/S0021-9258(19)63384-3","article-title":"Relationship of sialic acid to function and in\u00a0vivo survival of human factor VIII\/von Willebrand factor protein","volume":"252","author":"Sodetz","year":"1977","journal-title":"J\u00a0Biol Chem"},{"issue":"5","key":"2024062514452995100_bib20","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1182\/blood.V88.5.1692.1692","article-title":"Clearance of normal and type 2A von Willebrand factor in the rat","volume":"88","author":"Stoddart","year":"1996","journal-title":"Blood"},{"issue":"6","key":"2024062514452995100_bib21","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nm1760","article-title":"The Ashwell receptor mitigates the lethal coagulopathy of sepsis","volume":"14","author":"Grewal","year":"2008","journal-title":"Nat Med"},{"issue":"12","key":"2024062514452995100_bib22","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1111\/jth.13537","article-title":"N-linked glycan truncation causes enhanced clearance of plasma-derived von Willebrand factor","volume":"14","author":"O'Sullivan","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"issue":"14","key":"2024062514452995100_bib23","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1182\/blood-2018-09-874636","article-title":"Increased galactose expression and enhanced clearance in patients with low von Willebrand factor","volume":"133","author":"Aguila","year":"2019","journal-title":"Blood"},{"issue":"15","key":"2024062514452995100_bib24","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood-2016-04-709436","article-title":"N-linked glycans within the A2 domain of von Willebrand factor modulate macrophage-mediated clearance","volume":"128","author":"Chion","year":"2016","journal-title":"Blood"},{"issue":"4","key":"2024062514452995100_bib25","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1083\/jcb.102.4.1320","article-title":"Initial glycosylation and acidic pH in the Golgi apparatus are required for multimerization of von Willebrand factor","volume":"102","author":"Wagner","year":"1986","journal-title":"J\u00a0Cell Biol"},{"issue":"4","key":"2024062514452995100_bib26","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1182\/blood-2010-02-267450","article-title":"Specific N-linked glycosylation sites modulate synthesis and secretion of von Willebrand factor","volume":"116","author":"McKinnon","year":"2010","journal-title":"Blood"},{"issue":"1","key":"2024062514452995100_bib27","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1182\/blood-2012-02-410050","article-title":"O-linked glycosylation of von Willebrand factor modulates the interaction with platelet receptor glycoprotein Ib under static and shear stress conditions","volume":"120","author":"Nowak","year":"2012","journal-title":"Blood"},{"issue":"5","key":"2024062514452995100_bib28","doi-asserted-by":"crossref","first-page":"e37508","DOI":"10.1371\/journal.pone.0037508","article-title":"In\u00a0vivo analysis of the role of O-glycosylations of von Willebrand factor","volume":"7","author":"Badirou","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"2024062514452995100_bib29","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1172\/JCI116112","article-title":"O-linked carbohydrate of recombinant von Willebrand factor influences ristocetin-induced binding to platelet glycoprotein 1b","volume":"90","author":"Carew","year":"1992","journal-title":"J\u00a0Clin Invest"},{"issue":"7","key":"2024062514452995100_bib30","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1182\/blood-2003-02-0599","article-title":"Analysis of intracellular storage and regulated secretion of 3 von Willebrand disease-causing variants of von Willebrand factor","volume":"102","author":"Michaux","year":"2003","journal-title":"Blood"},{"issue":"5","key":"2024062514452995100_bib31","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCULATIONAHA.118.034532","article-title":"Genome-wide association transethnic meta-analyses identifies novel associations regulating coagulation factor VIII and von Willebrand factor plasma levels","volume":"139","author":"Sabater-Lleal","year":"2019","journal-title":"Circulation"},{"issue":"pt 8","key":"2024062514452995100_bib32","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1242\/jcs.114.8.1455","article-title":"Differential effect of GalNAcalpha-O-bn on intracellular trafficking in enterocytic HT-29 and Caco-2 cells: correlation with the glycosyltransferase expression pattern","volume":"114","author":"Gouyer","year":"2001","journal-title":"J\u00a0Cell Sci"},{"issue":"2","key":"2024062514452995100_bib33","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/hq0202.103997","article-title":"Amount of H antigen expressed on circulating von Willebrand factor is modified by ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels","volume":"22","author":"O'Donnell","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"2024062514452995100_bib34","doi-asserted-by":"crossref","first-page":"e12595","DOI":"10.1002\/rth2.12595","article-title":"Quantitative 3D microscopy highlights altered von Willebrand factor alpha-granule storage in patients with von Willebrand disease with distinct pathogenic mechanisms","volume":"5","author":"Swinkels","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"issue":"10","key":"2024062514452995100_bib35","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1111\/jth.15830","article-title":"Sustained VWF-ADAMTS-13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunction","volume":"20","author":"Fogarty","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"issue":"3","key":"2024062514452995100_bib36","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/jth.15598","article-title":"Osteoprotegerin modulates platelet adhesion to von Willebrand factor during release from endothelial cells","volume":"20","author":"Wohner","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"issue":"14","key":"2024062514452995100_bib37","doi-asserted-by":"crossref","first-page":"e2200249","DOI":"10.1002\/adhm.202200249","article-title":"Nanofiber topographies enhance platelet-fibrinogen scaffold interactions","volume":"11","author":"Kenny","year":"2022","journal-title":"Adv Healthc Mater"},{"issue":"5","key":"2024062514452995100_bib38","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/BF00702335","article-title":"Benzyl-N-acetyl-alpha-D-galactosaminide inhibits the sialylation and the secretion of mucins by a mucin secreting HT-29 cell subpopulation","volume":"13","author":"Delannoy","year":"1996","journal-title":"Glycoconj J"},{"issue":"9","key":"2024062514452995100_bib39","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/0959-8049(95)00248-H","article-title":"Inhibition of mucin synthesis by benzyl-alpha-GalNAc in KATO III gastric cancer and Caco-2 colon cancer cells","volume":"31A","author":"Byrd","year":"1995","journal-title":"Eur J Cancer"},{"issue":"43","key":"2024062514452995100_bib40","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1038\/s41388-018-0375-0","article-title":"C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer","volume":"37","author":"Lin","year":"2018","journal-title":"Oncogene"},{"issue":"2","key":"2024062514452995100_bib41","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3892\/ol.2021.12850","article-title":"C1GALT1 in health and disease","volume":"22","author":"Sun","year":"2021","journal-title":"Oncol Lett"},{"issue":"3","key":"2024062514452995100_bib42","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.devcel.2014.03.021","article-title":"A\u00a0two-tier Golgi-based control of organelle size underpins the functional plasticity of endothelial cells","volume":"29","author":"Ferraro","year":"2014","journal-title":"Dev Cell"},{"key":"2024062514452995100_bib43","doi-asserted-by":"crossref","first-page":"32473","DOI":"10.1038\/srep32473","article-title":"Weibel-Palade body size modulates the adhesive activity of its von Willebrand factor cargo in cultured endothelial cells","volume":"6","author":"Ferraro","year":"2016","journal-title":"Sci Rep"},{"issue":"12","key":"2024062514452995100_bib44","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1111\/jth.15084","article-title":"Modulation of endothelial organelle size as an antithrombotic strategy","volume":"18","author":"Ferraro","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"issue":"2","key":"2024062514452995100_bib45","doi-asserted-by":"crossref","first-page":"100085","DOI":"10.1016\/j.rpth.2023.100085","article-title":"Endothelial cell activation, Weibel-Palade body secretion, and enhanced angiogenesis in severe COVID-19","volume":"7","author":"Karampini","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"issue":"22","key":"2024062514452995100_bib46","doi-asserted-by":"crossref","first-page":"6974","DOI":"10.1182\/bloodadvances.2023010824","article-title":"VWF-ADAMTS13 axis dysfunction in children with sickle cell disease treated with hydroxycarbamide vs blood transfusion","volume":"7","author":"Fogarty","year":"2023","journal-title":"Blood Adv"},{"issue":"1","key":"2024062514452995100_bib47","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/jth.15528","article-title":"Desialylation of O-glycans activates von Willebrand factor by destabilizing its autoinhibitory module","volume":"20","author":"Voos","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"issue":"9","key":"2024062514452995100_bib48","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1182\/blood-2005-03-1153","article-title":"A\u00a0novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B","volume":"106","author":"Hulstein","year":"2005","journal-title":"Blood"},{"issue":"8","key":"2024062514452995100_bib49","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1182\/blood-2017-06-787853","article-title":"A\u00a0novel role for the macrophage galactose-type lectin receptor in mediating von Willebrand factor clearance","volume":"131","author":"Ward","year":"2018","journal-title":"Blood"},{"issue":"3","key":"2024062514452995100_bib50","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3324\/haematol.2020.274720","article-title":"Sialylation on O-linked glycans protects von Willebrand factor from macrophage galactose lectin-mediated clearance","volume":"107","author":"Ward","year":"2022","journal-title":"Haematologica"},{"issue":"16","key":"2024062514452995100_bib51","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1182\/blood-2010-08-303727","article-title":"Pathologic mechanisms of type 1 VWD mutations R1205H and Y1584C through in\u00a0vitro and in\u00a0vivo mouse models","volume":"117","author":"Pruss","year":"2011","journal-title":"Blood"},{"issue":"6","key":"2024062514452995100_bib52","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1083\/jcb.99.6.2123","article-title":"Biosynthesis of von Willebrand protein by human endothelial cells: processing steps and their intracellular localization","volume":"99","author":"Wagner","year":"1984","journal-title":"J\u00a0Cell Biol"},{"issue":"10","key":"2024062514452995100_bib53","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1111\/jth.14251","article-title":"Delimiting the autoinhibitory module of von Willebrand factor","volume":"16","author":"Deng","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"issue":"9","key":"2024062514452995100_bib54","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1111\/jth.13775","article-title":"A\u00a0discontinuous autoinhibitory module masks the A1 domain of von Willebrand factor","volume":"15","author":"Deng","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"2024062514452995100_bib55","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1038\/s41467-021-22634-x","article-title":"Activation of von Willebrand factor via mechanical unfolding of its discontinuous autoinhibitory module","volume":"12","author":"Arce","year":"2021","journal-title":"Nat Commun"},{"issue":"12","key":"2024062514452995100_bib56","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1182\/blood.2022016467","article-title":"Structures of VWF tubules before and after concatemerization reveal a mechanism of disulfide bond exchange","volume":"140","author":"Anderson","year":"2022","journal-title":"Blood"},{"issue":"26","key":"2024062514452995100_bib57","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1182\/blood.2022017153","article-title":"Assembly of von Willebrand factor tubules with in\u00a0vivo helical parameters requires A1 domain insertion","volume":"140","author":"Javitt","year":"2022","journal-title":"Blood"},{"issue":"20","key":"2024062514452995100_bib58","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1182\/blood-2015-10-673681","article-title":"Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States","volume":"127","author":"Flood","year":"2016","journal-title":"Blood"},{"issue":"21","key":"2024062514452995100_bib59","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1182\/blood-2017-05-786699","article-title":"Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels","volume":"130","author":"Lavin","year":"2017","journal-title":"Blood"},{"issue":"14","key":"2024062514452995100_bib60","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1182\/blood.2023022457","article-title":"Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studies","volume":"143","author":"Atiq","year":"2024","journal-title":"Blood"},{"issue":"13","key":"2024062514452995100_bib61","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1182\/bloodadvances.2020002038","article-title":"Low VWF: insights into pathogenesis, diagnosis, and clinical management","volume":"4","author":"O'Donnell","year":"2020","journal-title":"Blood Adv"},{"issue":"6","key":"2024062514452995100_bib62","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1182\/blood-2006-06-032706","article-title":"Variations in glycosylation of von Willebrand factor with O-linked sialylated T antigen are associated with its plasma levels","volume":"109","author":"van Schooten","year":"2007","journal-title":"Blood"},{"issue":"1","key":"2024062514452995100_bib63","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0092-8674(00)80964-2","article-title":"Mvwf, a dominant modifier of murine von Willebrand factor, results from altered lineage-specific expression of a glycosyltransferase","volume":"96","author":"Mohlke","year":"1999","journal-title":"Cell"},{"issue":"1","key":"2024062514452995100_bib64","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s13023-023-02879-z","article-title":"Congenital disorders of glycosylation (CDG): state of the art in 2022","volume":"18","author":"Francisco","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"2024062514452995100_bib65","first-page":"599","volume-title":"Essentials of Glycobiology","author":"Lefeber","year":"2022"},{"issue":"44","key":"2024062514452995100_bib66","doi-asserted-by":"crossref","first-page":"13657","DOI":"10.1073\/pnas.1515464112","article-title":"An intrinsic mechanism of secreted protein aging and turnover","volume":"112","author":"Yang","year":"2015","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/12\/3254\/2232177\/blooda_adv-2023-012499-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/12\/3254\/2232177\/blooda_adv-2023-012499-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T14:47:31Z","timestamp":1719326851000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/12\/3254\/515793\/O-glycan-determinants-regulate-VWF-trafficking-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,14]]},"references-count":66,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,6,25]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023012499","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,14]]}}}